You deserve an HIV treatment you can stick with, so talk with your doctor to see if SYMTUZA® is right for you.
The tolerability of SYMTUZA® has been studied across 2 clinical trials.
Over 1,100 people living with HIV were treated with SYMTUZA® in the trials.
People new to HIV treatment and people switching HIV treatments were a part of the trials.
Over 1,100 people living with HIV were treated with SYMTUZA® in the trials.
People new to HIV treatment and people switching HIV treatments were a part of the trials.
NO MORE THAN
of patients in any of the two trials stopped taking SYMTUZA® due to side effects through 11 months.
NO MORE THAN
of patients in any of the 2 trials stopped taking SYMTUZA® due to side effects through 11 months.
There was a low incidence of HIV treatment-related weight gain across both studies through 11 months.
There was a low incidence of HIV treatment-related weight gain across both studies through 11 months.
As with most medications, SYMTUZA® can cause side effects. The most common side effects occurring in at least 2% of patients taking SYMTUZA® were:
These are not all the possible side effects of SYMTUZA®. For more information, please refer to the Important Safety Information, including Boxed Warning, for SYMTUZA® and talk to your doctor.
Weight gain can impact an individual's overall health, and it can be a concern when starting a new HIV treatment.*
Certain HIV treatments may cause more weight gain than other treatments. Some individuals can gain more weight on certain treatments than others. Always talk to your doctor before making any changes to your treatment regimen.
patients had to stop taking SYMTUZA® due to weight gain in two key studies.†
patients had to stop taking SYMTUZA® due to weight gain in two key studies.†
*Long-term consequences of weight gain are not known. As research continues in this area, it's important to have ongoing conversations with your healthcare provider.
†Across 2 clinical trials, one patient taking SYMTUZA® experienced treatment-related weight gain. The average weight gain over 48 weeks was between 3.13 lbs (1.42 kg) and 3.84 lbs (1.75 kg) in 1,125 patients in the SYMTUZA® group, and ~1 lb (.45 kg) for 741 patients in the control group. The long-term impact of SYMTUZA® on weight has not been studied in clinical trials.
See what SYMTUZA® patients have to say about their HIV treatment.
"My doctor and I decided SYMTUZA® was the right treatment for me..."
"I choose to continue to take my medication, every day, on time. Just one pill a day."
"As a single mom working, and trying to do everything else, it's not easy to stop [and] take medication…I'm glad that my switch was right for me."
"The medicine is doing what it's supposed to do, keeping my numbers where they are, and that's what's most important."
Please see full Important Safety Information and Prescribing Information including Boxed Warning, for Symtuza®.
Learn what the treatment plan is like with one pill, once-daily SYMTUZA®.